Peripheral Neuropathies, Including Guillain-Barré Syndrome

Peripheral Neuropathies, Including Guillain-Barré Syndrome is a topic covered in the Harrison's Manual of Medicine.

To view the entire topic, please or purchase a subscription.

Harrison’s Manual of Medicine 19th edition provides 600+ internal medicine topics in a rapid-access format. Download Harrison’s App to iPhone, iPad, and Android smartphone and tablet. Explore these free sample topics:

Harrison’s Manual of Medicine - App + Web

-- The first section of this topic is shown below --

Approach to the patient

Peripheral neuropathy (PN) refers to a peripheral nerve disorder of any cause. Nerve involvement may be single (mononeuropathy) or multiple (polyneuropathy); pathology may be axonal or demyelinating. An approach to pts with suspected neuropathy appears in Fig. 193-1.

Seven initial questions:

  1. What systems are involved? Determine if symptoms and signs are predominantly motor, sensory, autonomic, or a combination of these. If only weakness is present without sensory or autonomic dysfunction, consider a motor neuropathy, neuromuscular junction disorder, or myopathy; myopathies usually have a proximal, symmetric pattern of weakness.
  2. What is the distribution of weakness? Polyneuropathy involves widespread and often symmetric dysfunction of the peripheral nerves that is usually distal more than proximal; mononeuropathy involves a single nerve, usually due to trauma or compression; multiple mononeuropathies (mononeuropathy multiplex) can be a result of multiple entrapments, vasculitis, or infiltration.
  3. What is the nature of the sensory involvement? Temperature loss or burning/stabbing pain suggests small fiber involvement. Vibratory or proprioceptive loss implicates large fibers.
  4. Is there evidence of upper motor neuron involvement? The most common cause is combined system degeneration with B12 deficiency, but should also consider copper deficiency, HIV infection, severe hepatic disease, and adrenomyeloneuropathy.
  5. What is the temporal evolution? Most neuropathies are insidious and slowly progressive. Rapidly evolving neuropathies are often inflammatory, including acute inflammatory demyelinating polyneuropathy (AIDP) or Guillain-Barré syndrome (GBS); subacute evolution suggests an inflammatory, toxic, or nutritional cause; chronic neuropathies that are long-standing over years may be hereditary.
  6. Is there evidence for a hereditary neuropathy? Consider in pts with a slowly progressive distal weakness over many years with few sensory symptoms but significant sensory deficits on clinical examination. Most common is Charcot-Marie-Tooth disease (CMT; look for foot abnormalities such as high or flat arches and hammer toes as well as scoliosis).
  7. Does the pt have other medical conditions? Inquire about associated medical conditions (e.g., diabetes, systemic lupus erythematosus); preceding or concurrent infections (e.g., diarrheal illness preceding GBS); surgeries (e.g., gastric bypass and nutritional neuropathies); medications (toxic neuropathy); over-the-counter vitamin preparations (B6); alcohol, dietary habits; and use of dentures (because fixatives contain zinc that can lead to copper deficiency).

Based on the answers to these seven key questions, neuropathic disorders can be classified into several patterns based on the pattern of sensory, motor, and autonomic involvement (Table 193-1).

FIGURE 193-1

Approach to evaluation of peripheral neuropathies. CIDP, chronic inflammatory demyelinating polyradiculoneuropathy; EDx, electrodiagnostic studies; GBS, Guillain-Barré syndrome; IVIg, intravenous immunoglobulin.

Pattern 1: Symmetric proximal and distal weakness with sensory loss
 Consider: inflammatory demyelinating polyneuropathy (GBS and CIDP)
Pattern 2: Symmetric distal sensory loss with or without distal weakness
 Consider: cryptogenic or idiopathic sensory polyneuropathy (CSPN), diabetes mellitus and other metabolic disorders, drugs, toxins, familial (HSAN), CMT, amyloidosis, and others
Pattern 3: Asymmetric distal weakness with sensory loss
With involvement of multiple nerves
 Consider: multifocal CIDP, vasculitis, cryoglobulinemia, amyloidosis, sarcoid, infectious (leprosy, Lyme, hepatitis B, C, or E, HIV, CMV), HNPP, tumor infiltration
With involvement of single nerves/regions
 Consider: may be any of the above but also could be compressive mononeuropathy, plexopathy, or radiculopathy
Pattern 4: Asymmetric proximal and distal weakness with sensory loss
 Consider: polyradiculopathy or plexopathy due to diabetes mellitus, meningeal carcinomatosis or lymphomatosis, hereditary plexopathy (HNPP, HNA), idiopathic
Pattern 5: Asymmetric distal weakness without sensory loss
With upper motor neuron findings
 Consider: motor neuron disease
Without upper motor neuron findings
 Consider: progressive muscular atrophy, juvenile monomelic amyotrophy (Hirayama’s disease), multifocal motor neuropathy, multifocal acquired motor axonopathy
Pattern 6: Symmetric sensory loss and distal areflexia with upper motor neuron findings
 Consider: Vitamin B12, vitamin E, and copper deficiency with combined system degeneration with peripheral neuropathy, hereditary leukodystrophies (e.g., adrenomyeloneuropathy)
Pattern 7: Symmetric weakness without sensory loss
With proximal and distal weakness
 Consider: SMA
With distal weakness
 Consider: hereditary motor neuropathy (“distal” SMA) or atypical CMT
Pattern 8: Asymmetric proprioceptive sensory loss without weakness
 Consider causes of a sensory neuronopathy (ganglionopathy):
 Cancer (paraneoplastic)
 Sjögren’s syndrome
 Idiopathic sensory neuronopathy (possible GBS variant)
 Cisplatin and other chemotherapeutic agents
 Vitamin B6 toxicity
 HIV-related sensory neuronopathy
Pattern 9: Autonomic symptoms and signs
 Consider neuropathies associated with prominent autonomic dysfunction:
 Hereditary sensory and autonomic neuropathy
 Amyloidosis (familial and acquired)
 Diabetes mellitus
 Idiopathic pandysautonomia (may be a variant of Guillain-Barré syndrome)
 HIV-related autonomic neuropathy
 Vincristine and other chemotherapeutic agents
Abbreviations: CIDP, chronic inflammatory demyelinating polyneuropathy; CMT, Charcot-Marie-Tooth disease; GBS, Guillain-Barré syndrome; HNA, hereditary neuralgic amyotrophy; HNPP, hereditary neuropathy with liability to pressure palsies; HSAN, hereditary sensory and autonomic neuropathy; SMA, spinal muscular atrophy.

-- To view the remaining sections of this topic, please or purchase a subscription --


* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Peripheral Neuropathies, Including Guillain-Barré Syndrome ID - 623119 Y1 - 2017 PB - Harrison's Manual of Medicine UR -é_Syndrome ER -